Rs75076352

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.

Germ-line mutations in nonsyndromic pheochromocytoma.

Cushing's syndrome due to ectopic ACTH secretion by bilateral pheochromocytomas in multiple endocrine neoplasia type 2A.

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

Haplotype analysis of MEN 2 mutations.

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.